Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial
- Авторлар: Shilo V.Y.1, Alihanova L.I2, Babich V.P3, Vishnevskii K.A4, Zhdanova I.V5, Zuev A.V6, Kalachik O.V7, Kotova L.I8, Legotin A.B9, Sabodash A.B10, Suchkov V.N11, Timokhovskaia G.Y.12, Toropilov D.M13, Tutin A.P14, Priluckij S.V15, Fedotova L.A16, Khadikova N.G17, Morozova M.A18, Bolsun D.D18, Dokukina E.A18, Linkova Y.N18, Ivanov R.A18
-
Мекемелер:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Republican Clinical Hospital Ministry of health Republic of Tatarstan
- LLC Medical center "Nephros"
- Saint-Petersburg State Budgetary Health Care Institution "City Hospital №15"
- The Federal State Budgetary Institute "The Nikiforov Russian Center of Emergency and Radiation Medicine” The Ministry of Russian Federation for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
- State Budgetary Health Care Institution of the Republic of Karelia "Republican Hospital named after V.A. Baranov"
- State institution "Minsk scientific and practical center of surgery, transplantology and hematology"
- Budgetary health care institution of Omsk
- St. Petersburg State Budgetary Healthcare Institution "City Hospital of the Holy Martyr Elizabeth"
- LLC "BBraun Avitum Russland Clinics"
- St. Petersburg State Budgetary Healthcare Institution "City Mariinsky Hospital"
- St. Petersburg State Health Care Institution "City Clinical Hospital №31"
- 4-th City clinical hospital named after Mikalaj Sauchanka
- LLC "Kupchinsky Center of outpatient dialysis"
- Minsk Regional Clinical Hospital
- LLC "Nefroline-Novosibirsk"
- St. Petersburg State Medical Academy "Nikolaev Hospital"
- JSC BIOCAD
- Шығарылым: № 2 (2019)
- Беттер: 6-15
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273166
- DOI: https://doi.org/10.18565/nephrology.2019.2.06-15
- ID: 273166
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
V. Shilo
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: nephrolog@gmail.com
PhD in Medical Science, Associate Professor at the Department of Nephrology
L. Alihanova
Republican Clinical Hospital Ministry of health Republic of Tatarstan
V. Babich
LLC Medical center "Nephros"
K. Vishnevskii
Saint-Petersburg State Budgetary Health Care Institution "City Hospital №15"
I. Zhdanova
The Federal State Budgetary Institute "The Nikiforov Russian Center of Emergency and Radiation Medicine” The Ministry of Russian Federation for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
A. Zuev
State Budgetary Health Care Institution of the Republic of Karelia "Republican Hospital named after V.A. Baranov"
O. Kalachik
State institution "Minsk scientific and practical center of surgery, transplantology and hematology"
L. Kotova
Budgetary health care institution of Omsk
A. Legotin
St. Petersburg State Budgetary Healthcare Institution "City Hospital of the Holy Martyr Elizabeth"
A. Sabodash
LLC "BBraun Avitum Russland Clinics"
V. Suchkov
St. Petersburg State Budgetary Healthcare Institution "City Mariinsky Hospital"
G. Timokhovskaia
St. Petersburg State Health Care Institution "City Clinical Hospital №31"
D. Toropilov
4-th City clinical hospital named after Mikalaj Sauchanka
A. Tutin
LLC "Kupchinsky Center of outpatient dialysis"
S. Priluckij
Minsk Regional Clinical Hospital
L. Fedotova
LLC "Nefroline-Novosibirsk"
N. Khadikova
St. Petersburg State Medical Academy "Nikolaev Hospital"
M. Morozova
JSC BIOCAD
D. Bolsun
JSC BIOCAD
E. Dokukina
JSC BIOCAD
Yu. Linkova
JSC BIOCAD
R. Ivanov
JSC BIOCAD
Әдебиет тізімі
- Клинические рекомендации. Диагностика и лечение анемии при хронической болезни почек. Москва, 2014. [Klinicheskiye rekomendatsii. Diagnostika i lecheniye anemiipri khronicheskoy boleznipochek. M., 2014. (In Russ.)
- Шило В.Ю. Новый эритропоэз-стимулирующий препарат Аранесп (дарбэпоэтин альфа) в коррекции анемии почечного генеза. Нефрология и диализ. 2007;9(3):1-9. [Shylo V.Yu. New erythropoiesis-stimulating drug Aranesp (darbepoetin alfa) with the correction of renal anemia. Nefrologiya i dializ. 2007;9(3):1-9. (In Russ.)]
- Macdougall I.C., Padhi D., Jang G. Pharmacology of darbepoetin alfa. Nephrol. Dial. Transplant. 2007. Vol. 22. Suppl 4. P. iv2-iv9.
- Бабичева Л.Г., Поддубная И.В. Лечение анемии в онкологии: роль нового стимулятора эритропоэза Аранесп (дарбэпоэтин альфа). Современная онкология. 2007;9(3):69-74. [Babicheva L.G., Poddubnaya I.V Treatment of anemia in oncology: the role of the new erythropoiesis stimulator Aranesp (darbepoetin alfa). Sovremennaya onkologiya. 2007; 9 (3): 69-74.(In Russ.)
- MacDougall I.C. CERA (continuous erythropoietin receptor activator): a new erythropoiesis-stimulating agent for the treatment of anemia. Curr. Hematol. Rep. 2005;4:436-440.
- Liu L, LiH., Hamilton S.R., Gomathinayagam S., Rayfield W.J., van Maanen M., Yin K.C., Hong L., Prueksaritanont T. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin. J. Pharm. Sci. 2012;101(12):4414-4418.
- https://clinicaltrials.gov/ct2/show/NCT02731469
- Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Published: 2009 (v4.03: June 14, 2010) U.S. Department of health and human services National Institutes of Health National Cancer Institute. https://www. eortc.be/services/doc/ctc/CTCAE_4.(03__2010-06-14_QuickReference_5x7.
- Locatelli F., Villa G, de Francisco A.L.M., et al. Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration. Current medical research and opinion, 2007;23:969-979.
- EMEA. Scientific discussion. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Scientific_Discussion/human/000739/ WC500033669.pdf
- Chow S.C., Shao J., Wang H. Sample Size Calculations in Clinical Research, 2nd Edition, Chapman & Hall/CRC, 2008.
- https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=10238ab1-0e62-44da-acca-01aaa33a659c&t=
- Moher D.,1 Hopewell S., F Schulz K., Montori V., Gotzsche P., Devereaux P., Elbourne D., Egger M., Altman D. CONSORT 2010. Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:869р. doi: 10.1136/bmj.c869.
- Tenny S/, Gossman W/G. Evidence Based Medicine (EBM) [Updated 2018 May 13]. https://www.ncbi.nlm.nih.gov/books/NBK470182/
- Rajiv Agarwal, Mechanisms and mediators of hypertension induced by erythropoietin and related molecules. Nephrology Dialysis Transplantation. 2018;33(10):1690-1698. Doi: https://doi.org/10.1093/ndt/gfx324
- Kato S., Chmielewski M., Honda H., Pecoits-Filho R., Matsuo S., Yuzawa Y., Tranaeus A., Stenvinkeland P., Lindholm B. Aspects of Immune Dysfunction in End-stage Renal Disease. CJASN. 2008;3(5):1526-1533. Doi: https://doi. org/10.2215/CJN.00950208
- Lepe-Zuniga JL, Morales-Molina P, Garcia-Nandayapa GA. End stage renal disease lymphopenia; characterization and clinical correlation. Rev. Med. Inst. Mex. Seguro Soc. 2016;54(4):446-453.
- https://www.who.int/medicines/areas/quality_safety/safety_efficacy/ trainingcourses/definitions.pdf
Қосымша файлдар
![](/img/style/loading.gif)